^
    BIOMARKER:

    LMO7-ALK fusion

    i
    Other names: LMO7, LIM Domain 7, FBX20, F-Box Only Protein 20, KIAA0858, FBXO20, LIM Domain Only Protein 7, LMO-7, LOMP, Zinc-Finger Domain-Containing Protein, LIM Domain Only 7 Protein, F-Box Protein Fbx20, LIM Domain Only 7, LMO7b, NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
    Entrez ID:
    238; 4008
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others

    Associations

    Heatmap
    News
    Twitter
    Trials
    LMO7-ALK fusion
    NSCLC
    alectinib
    Resistant: C3 – Early Trials
    J Cell Mol Med - 3 weeks
    LMO7-ALK fusion
    NSCLC
    crizotinib + X-396
    Sensitive: C3 – Early Trials
    J Cell Mol Med - 3 weeks